miR-369-3p serves as prognostic factor and regulates cancer progression of hepatocellular carcinoma

Can Chen1,2, Yi Zong1,3, Jiaojiao Tang2

  • 1The Graduate School of Fujian Medical University, Fuzhou, Fujian, 350108, PR China.

Personalized Medicine
|April 1, 2021
PubMed

Insights

MicroRNA-369-3p (miR-369-3p) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Its reduced expression in HCC inhibits cancer cell proliferation, migration, and invasion by targeting SOX4.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Understanding the molecular mechanisms underlying HCC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of microRNA-369-3p (miR-369-3p) in hepatocellular carcinoma (HCC).
  • To determine the potential of miR-369-3p as a therapeutic target in HCC.

Main Methods:

  • Quantitative real-time reverse transcription-PCR (qRT-PCR) for miR-369-3p expression analysis.
  • Cell counting kit-8 (CCK-8) and Transwell assays to assess cell proliferation, migration, and invasion.
  • Bioinformatic analysis and luciferase reporter assays to identify direct targets of miR-369-3p.

Main Results:

  • miR-369-3p expression was significantly downregulated in HCC tissues and cell lines compared to normal controls.
  • Overexpression of miR-369-3p in HCC cell lines (Hep 3B, Huh7) inhibited cell proliferation, migration, and invasion.
  • SOX4 was identified as a direct target gene regulated by miR-369-3p.

Conclusions:

  • miR-369-3p functions as a tumor suppressor in hepatocellular carcinoma.
  • Targeting SOX4 by miR-369-3p represents a potential therapeutic strategy for HCC treatment.